Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846252 | 12784625 | 2 | F | 20160922 | 20160927 | 20160929 | EXP | GR-VALIDUS PHARMACEUTICALS LLC-GR-2016VAL002699 | VALIDUS | VALSAMIDI K, ORFANOU E.. TAKAYASU ARTERITIS: CASE REPORT. REPORT A^ PEDIATRIC CLINIC ATHENS UNIVERSITY. 2016;66 (2) | 12.00 | YR | F | Y | 0.00000 | 20160929 | OT | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127846252 | 12784625 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | UNK | U | UNKNOWN | 16273 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127846252 | 12784625 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127846252 | 12784625 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127846252 | 12784625 | Drug ineffective | |
| 127846252 | 12784625 | Pulmonary oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |